Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Prognostic scoring models in parotid gland carcinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Surgical treatment of the neck in patients with salivary gland carcinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Characteristics of patients reporting symptoms by open-ended questions in specialist palliative care

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Jammbe Z Musoro
  • Corneel Coens
  • Susanne Singer
  • Silke Tribius
  • Sjoukje F Oosting
  • Mogens Groenvold
  • Christian Simon
  • Jean-Pascal Machiels
  • Vincent Grégoire
  • Galina Velikova
  • Kim Cocks
  • Mirjam A G Sprangers
  • Madeleine T King
  • Andrew Bottomley
Vis graf over relationer

BACKGROUND: We aimed to estimate minimally important difference (MID) for interpreting group-level change over time for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire core 30 (EORTC QLQ-C30) scores in head and neck cancer.

METHODS: Data were derived retrospectively from two published EORTC trials. Clinical anchors were selected using correlation strength and clinical plausibility of the given anchor/QLQ-C30 scale pair. MIDs for within-group and between-group change were estimated via the mean change method and linear regression, respectively. Distribution-based MIDs were also examined. MIDs for two of the scales, dyspnea and nausea/vomiting, are more uncertain considering their low correlations with the anchors.

RESULTS: Anchor-based MIDs could be determined for deterioration in 7 of the 14 QLQ-C30 scales assessed, and in 3 scales for improvement. MIDs varied by scale, direction of change, and anchor. Absolute MID values ranged from 5 to 15 points for within-group change and 4 to 12 for between-group change. Most MIDs were within 4 to 10 points.

CONCLUSIONS: Our findings, if confirmed, will aid interpreting changes in selected QLQ-C30 scale scores over time and inform sample size calculations in future clinical trials in head and neck cancer.

OriginalsprogEngelsk
TidsskriftHead and Neck
Vol/bind42
Udgave nummer11
Sider (fra-til)3141-3152
Antal sider12
ISSN1043-3074
DOI
StatusUdgivet - nov. 2020

Bibliografisk note

© 2020 Wiley Periodicals LLC.

ID: 61353431